Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of inducible basophil biomarkers: Time, temperature and transportation.
Kim T, Yu J, Li H, Scarupa M, Wasserman RL, Economides A, White M, Ward C, Shah A, Jones D, Rathkopf M, Frye K, Aybar A, Shayegan S, Enav B, Ispas L, Loizou D, Fitzhugh D, Tracy J, Friedlander J, Jacobs Z, Matz J, Golden D, McNeil D, McCann W, Copenhaver C, Factor J, Gupta R, Alpan O, Plassmeyer M, Sønder SU. Kim T, et al. Among authors: wasserman rl. Cytometry B Clin Cytom. 2021 Nov;100(6):632-644. doi: 10.1002/cyto.b.21991. Epub 2021 Feb 4. Cytometry B Clin Cytom. 2021. PMID: 33539657 Free PMC article.
Oral immunotherapy for food allergy: The FAST perspective.
Wasserman RL, Jones DH, Windom HH. Wasserman RL, et al. Ann Allergy Asthma Immunol. 2018 Sep;121(3):272-275. doi: 10.1016/j.anai.2018.06.011. Epub 2018 Jun 19. Ann Allergy Asthma Immunol. 2018. PMID: 29928983 No abstract available.
Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study.
Rubinstein A, Mabudian M, McNeil D, Patel NC, Wasserman RL, Gupta S, Carrasco P, Chen J, Garcia E, Nagy A, Yel L. Rubinstein A, et al. Among authors: wasserman rl. J Clin Immunol. 2024 Aug 19;44(8):181. doi: 10.1007/s10875-024-01769-8. J Clin Immunol. 2024. PMID: 39158670 Free PMC article.
An Approach to the Office-Based Practice of Food Oral Immunotherapy.
Wasserman RL, Factor J, Windom HH, Abrams EM, Begin P, Chan ES, Greenhawt M, Hare N, Mack DP, Mansfield L, Ben-Shoshan M, Stukus DR, Leek TV, Shaker M. Wasserman RL, et al. J Allergy Clin Immunol Pract. 2021 May;9(5):1826-1838.e8. doi: 10.1016/j.jaip.2021.02.046. Epub 2021 Mar 5. J Allergy Clin Immunol Pract. 2021. PMID: 33684637 Review.
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency.
Wasserman RL, Church JA, Stein M, Moy J, White M, Strausbaugh S, Schroeder H, Ballow M, Harris J, Melamed I, Elkayam D, Lumry W, Suez D, Rehman SM. Wasserman RL, et al. J Clin Immunol. 2012 Aug;32(4):663-9. doi: 10.1007/s10875-012-9656-5. Epub 2012 Mar 6. J Clin Immunol. 2012. PMID: 22392046 Free PMC article. Clinical Trial.
Office-based oral immunotherapy for food allergy is safe and effective.
Wasserman RL, Sugerman RW, Mireku-Akomeah N, Mansfield L, Baker JW. Wasserman RL, et al. J Allergy Clin Immunol. 2011 Jan;127(1):290-1; author reply 291-2. doi: 10.1016/j.jaci.2010.08.052. Epub 2010 Oct 30. J Allergy Clin Immunol. 2011. PMID: 21040956 No abstract available.
131 results